Table 2.

Relationships between inflammatory indices and numbers of disorders with body composition

	OSO/0	OSO/1	OSO/2	OSO/3	P-value
WBC	5.60 (4.70–7.00)	6.20 (5.40–7.30)	6.20 (5.20–7.20)	6.90 (5.60–7.90)*	0.005
SIRI	0.38 (0.27–0.54)	0.57 (0.43–0.82)*	0.59 (0.43–0.78)*†	0.75 (0.56–0.98)*†‡	< 0.001
AISI	77.76 (51.10–125.57)	129.68 (102.77–198.49)*	142.64 (98.60–192.39)*	188.60 (132.53–236.71)*†‡	< 0.001
NLR	1.42 (1.21–1.60)	1.91 (1.72–2.23) *	1.95 (1.75–2.22) *	2.20 (1.99–2.61) *†‡	< 0.001
PLR	97.56 (80.63–120.36)	123.30 (103.57–152.69) *	131.69 (109.75–158.71) *	127.96 (109.35–161.19) *	< 0.001
LMR	7.44 (5.86–10.42)	6.07 (4.65–7.81)*	6.15 (4.88–7.98)*	5.33 (4.37–6.83)*‡	< 0.001

Continuous variables were expressed as frequency (percentage). The Kruskal–Wallis test with the Bonferroni correction was used to examine differences between groups

Abbreviations: PLR Platelet-to-lymphocyte ratio, NLR Neutrophil-to-lymphocyte ratio, WBC White blood cells, LMR Lymphocyte-to-monocyte ratio, AISI Aggregate index of systemic inflammation, SIRI Systemic inflammation response index

*P < 0.05 compared with the normal group

†P < 0.05 compared with the group with one disorder

‡P > 0.05 compared with the group with two disorders